Compound information
- Natural Products
- ZC658503
- Molecular Formula
- C14H20N2O3
- Molecular Weight
- 264.1473925 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1R,2S)-1-carbamoyl-2-methyl-butyl]carbamate
- InChI
- InChI=1S/C14H20N2O3/c1-3-10(2)12(13(15)17)16-14(18)19-9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3,(H2,15,17)(H,16,18)/t10-,12+/m0/s1
- InChI Key
- PDGQPWKDTCRXMR-CMPLNLGQSA-N
- SMILES
- CC[C@H](C)[C@@H](NC(=O)OCc1ccccc1)C(N)=O
- Source
- ZINC000034319261
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 81.42 Å2 | LogP | 2.043 |
LogS | -3.116 | LogD | 2.802 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.164 | Pgp substrate | 0.015 |
HIA | 0.967 | F20 % | 0.995 |
F30 % | 0.37 | Caco-2 | -4.738 |
MDCK | -4.671 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.949 | PPB | 60.41 |
VD | 0.622 | Fu | 0.65 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.08 | CYP1A2 substrate | 0.667 |
CYP2A6 substrate | 0.465 | CYP2B6 substrate | 0.575 |
CYP2C19 inhibitor | 0.244 | CYP2C19 substrate | 0.892 |
CYP2C8 substrate | 0.708 | CYP2C9 inhibitor | 0.057 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.012 |
CYP2D6 substrate | 0.964 | CYP2E1 substrate | 0.574 |
CYP3A4 inhibitor | 0.011 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.6 | CL | 7.727 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.009 | Hepatotoxicity | 0.568 |
Mutagenicity | 0.062 | Rat Oral Acute Toxicity | 0.024 |
FDAMDD | 0.045 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.046 | Eye Corrosion | 0.003 |
Eye Irritation | 0.363 | Respiratory Toxicity | 0.002 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.153 | IGC50 | 2.452 |
LC50FM | 3.533 | LC50DM | 4.811 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.122 | NR-AR-LBD | 0.231 |
NR-AhR | 0.003 | NR-Aromatase | 0.044 |
NR-ER | 0.284 | NR-ER-LBD | 0.328 |
NR-PPAR-gamma | 0.197 | SR-ARE | 0.046 |
SR-ATAD5 | 0.292 | SR-HSE | 0.082 |
SR-MMP | 0.007 | SR-p53 | 0.015 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.